Molecular Diagnostics

Genetic Risk Factors Found in Gestational Diabetes
Gestational diabetes mellitus (GDM) is a common pregnancy complication affecting 6%–15% of pregnancies globally. Although the condition resolves after delivery in most cases, women with a history of GDM have a more than sevenfold increased risk of developing type 2 diabetes (T2D) compared with women with a normoglycemic pregnancy. More...26 Feb 2020


Novel Blood Tests Predict Progression of Parkinson's Disease
It is well established that the cumulative incidence of dementia associated with Parkinson’s disease (PD) is approaching 80% and individuals with PD are five to six times more likely to develop cognitive impairment than age-matched controls. More...25 Feb 2020

Elevated Levels of Certain Immunoproteosome Components Predict Potential Success of Checkpoint Inhibitor Therapy in Melanoma Patients
Increased expression of two protein members of the “immunoproteosome” can serve as important biomarkers for stratifying melanoma patients for immune-checkpoint treatment. More...25 Feb 2020

Proteogenomic Characterization of Endometrial Carcinoma Analyzed
Endometrial cancer is a cancer that arises from the endometrium which is the lining of the uterus or womb. It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. More...24 Feb 2020

Uric Acid in Saliva Is a Biomarker for Body Fat Accumulation in Adolescents
The noninvasive measurement of uric acid in saliva has been shown to be an important marker of body fat accumulation in adolescents, which demonstrates the clinical relevance of saliva for detection of early metabolic changes and monitoring of nutritional status. More...24 Feb 2020

Ratio of Serum Very-long-chain to Long-chain Ceramides Is Predictive of Dementia Risk
Results obtained by a large community-based study showed that the ratio of very long‐chain to long‐chain ceramides in the blood was associated with risk of developing various types of dementia including Alzheimer's disease (AD). More...24 Feb 2020
In Other News
Factor IX Inhibitor Incidence in Pediatric Hemophilia B Examined
Several Genes Linked to Long QT Syndrome Reappraised
Modular Targeted Capture Assay Detects Clinically Significant Oncology Alterations
Assessment of Circulating Tumor Cells Identifyies Stage III Melanoma Patients at Risk for Relapse
Lung Adenocarcinoma Genomic Features Differ in East Asians, Europeans
Autonomous Microchannel Analyzer Combines with Smartphone for Off-Site Disease Diagnostics
Protein Panel Predicts Risk for Development of Cerebral Small Vessel Disease
Blood Test Lead to Earlier Detection of Gastrointestinal Cancers
Rapid Antigenic Diagnostic Test Validated for Ebola Virus Disease
Lipocalin 2 Identified as Biomarker for Differential Diagnosis of Vascular Dementia
CDC Provides Test Protocol for Novel Coronavirus
Lung Cancer Liquid Biopsy Guides MRD-Directed Adjuvant Therapy
Detection of Pathogenic Microorganisms in Semen by Sequencing Sperm RNA
Single-Cell Sequencing Identifies Breast Cancer Risk
Novel Enrichment Technology Indicates High Performance for Multi-Cancer Detection
Liquid Biopsy Predicts Prognosis of Gastric Cancer Following Chemotherapy or Surgery
Heart Transplant Monitoring Test Validated
Real-Time PCR Developed for Eumycetoma Diagnosis
Technique Predicts Cancer Recurrence Risk for Melanoma Patients
Loop-Mediated Isothermal Amplification Discriminates Yaws Bacterium
Urinary Metabolite GWAS Leads to Biomarkers of Kidney Disease
Blood Test Measuring anti-Müllerian Hormone Predicts Time to a Woman’s Final Menstrual Period
A Needle Biopsy-based Proteogenomics Approach for Cancer Diagnosis
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








